ANTIBODIES TO TUMOR-ASSOCIATED GANGLIOSIDES (GM2 AND GD2): POTENTIAL FOR SUPPRESSION OF MELANOMA RECURRENCE
- 1 January 1985
- book chapter
- Published by Elsevier
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.Proceedings of the National Academy of Sciences, 1982
- Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.Proceedings of the National Academy of Sciences, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- [10] Gangliosides: Structure, isolation, and analysisPublished by Elsevier ,1982
- In vitro production of human antibody to a tumour-associated foetal antigenBritish Journal of Cancer, 1981
- A procedure for the quantitative isolation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Oncofoetal antigen I: a target for immune cytolysis of human cancerBritish Journal of Cancer, 1979
- Immune cytolysis of human malignant melanoma by antibody to oncofetal antigen I (OFA-I)Cancer Immunology, Immunotherapy, 1979
- Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patientsInternational Journal of Cancer, 1978
- EB virus-induced B lymphocyte cell lines producing specific antibodyNature, 1977